Sensus Healthcare Stock Forecast, Price & News

Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions

Is Sensus Healthcare a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sensus Healthcare stock.
View analyst ratings for Sensus Healthcare or view top-rated stocks.

How has Sensus Healthcare's stock price been impacted by Coronavirus (COVID-19)?

Sensus Healthcare's stock was trading at $3.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SRTS shares have increased by 138.5% and is now trading at $7.75.
View which stocks have been most impacted by COVID-19.

Are investors shorting Sensus Healthcare?

Sensus Healthcare saw a increase in short interest in December. As of December 31st, there was short interest totaling 130,300 shares, an increase of 28.4% from the December 15th total of 101,500 shares. Based on an average daily volume of 219,200 shares, the days-to-cover ratio is presently 0.6 days. Currently, 1.1% of the company's shares are sold short.
View Sensus Healthcare's Short Interest.

When is Sensus Healthcare's next earnings date?

Sensus Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Sensus Healthcare.

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) released its earnings results on Thursday, November, 4th. The company reported $0.01 EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.01) by $0.02. The company earned $5.53 million during the quarter, compared to analysts' expectations of $5.38 million. Sensus Healthcare had a negative trailing twelve-month return on equity of 0.87% and a negative net margin of 0.95%. During the same quarter in the prior year, the company earned ($0.10) earnings per share.
View Sensus Healthcare's earnings history.

What price target have analysts set for SRTS?

4 analysts have issued twelve-month price targets for Sensus Healthcare's stock. Their forecasts range from $6.00 to $12.00. On average, they expect Sensus Healthcare's share price to reach $9.33 in the next twelve months. This suggests a possible upside of 20.4% from the stock's current price.
View analysts' price targets for Sensus Healthcare or view top-rated stocks among Wall Street analysts.

Who are Sensus Healthcare's key executives?

Sensus Healthcare's management team includes the following people:

• Joseph C. Sardano, Chairman, President & Chief Executive Officer
• Nicolas Soro, Chief Operating Officer
• Javier Rampolla, Chief Financial Officer
• Russ Price, Chief Technology Officer
• Ziv Karni, Chief Scientific Officer

Who are some of Sensus Healthcare's key competitors?

Some companies that are related to Sensus Healthcare include Anika Therapeutics (ANIK), IRadimed (IRMD), SeaSpine (SPNE), Vapotherm (VAPO), Accuray (ARAY), Apyx Medical (APYX), Pulse Biosciences (PLSE), Utah Medical Products (UTMD), InfuSystem (INFU), Tactile Systems Technology (TCMD), Assure (ARHH), Liquidia (LQDA), Westaim (WEDXF), AVITA Medical (RCEL) and Co-Diagnostics (CODX).
View all of SRTS's competitors.

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).

When did Sensus Healthcare IPO?

(SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

What is Sensus Healthcare's stock symbol?

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

How do I buy shares of Sensus Healthcare?

Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sensus Healthcare's stock price today?

One share of SRTS stock can currently be purchased for approximately $7.75.

How much money does Sensus Healthcare make?

Sensus Healthcare has a market capitalization of $128.78 million and generates $9.58 million in revenue each year. The company earns $-6.84 million in net income (profit) each year or ($0.02) on an earnings per share basis.

How many employees does Sensus Healthcare have?

Sensus Healthcare employs 42 workers across the globe.

What is Sensus Healthcare's official website?

The official website for Sensus Healthcare is www.sensushealthcare.com.

Where are Sensus Healthcare's headquarters?

Sensus Healthcare is headquartered at 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487.

How can I contact Sensus Healthcare?

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at (561) 922-5808, via email at [email protected], or via fax at 561-948-2071.